Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Minneapolis, Minnesota 55455


Purpose:

The primary objective of this research is to measure neurochemicals in the activated human brain during both normoxia (normal oxygen availability) and induced mild hypoxia (reduced oxygen availability).


Study summary:

The goal is to determine the effect of mild hypoxia on human brain energy metabolism of healthy young adult subjects. For this purpose, the Investigator will utilize non-invasive imaging modalities based on functional magnetic resonance imaging (fMRI) and spectroscopy (fMRS), while subjects are exposed to well-controlled gas mixtures that resembles conditions of either normoxia or mild hypoxia. Identifying the impact of mild hypoxia on functional brain energy metabolism in the healthy human brain is a crucial step for generating hypotheses in multiple patient populations that experience mild hypoxia as consequence of their pathological condition, such as in sleep apnea and traumatic brain injury. The Investigator hypothesize that the energetic demands of neuronal activation as revealed by fMRS will not be affected by mild hypoxia, despite an altered hemodynamic response observed with fMRI.


Criteria:

Inclusion Criteria: - Those volunteers who are evaluated as normal and not met exclusion criteria will be potential candidates for this study. Exclusion Criteria: - Subjects with any type of bio-implant activated by mechanical, electronic, or magnetic means (e.g. cochlear implants, pacemakers, neurostimulators, biostimulators, electronic infusion pumps, etc.). - Subjects with any type of ferromagnetic bio-implant that could potentially be displaced or damaged, such as aneurysm clips, metallic skull plates, etc. - Pregnant females (if questionable doubt, self-test with over the counter pregnancy kit). - Subjects that exhibit noticeable anxiety and/or claustrophobia. - Subjects who cannot adhere to the experimental protocol for any reason. - Subjects who have cardiac or known circulatory impairment, and/or the inability to perspire (poor thermoregulatory function). - Subjects who have known conditions which can lead to emergency medical care. - Been diagnosed by a physician as having a psychiatric disorder, substance abuse, neurological, cardiovascular. - Been diagnosed by a physician as having respiratory diseases. - Had a brain tumor or stroke. - Started taking chemotherapy or immunomodulatory agents, or had any radiation treatment that could affect the brain. - Had two or more seizures, or been given a diagnosis of epilepsy. - Gotten a non-removable piercing or permanent eyeliner. - Had a head injury that caused you to lose consciousness for more than 30 minutes or have amnesia for more than 24 hours. - Anyone with a history of sleep apnea or head trauma that may have caused Traumatic Brain Injury (TBI). - Gotten some type of metal in your body, either from a medical procedure or an injury. - Male subjects with long beard which wouldn't allow a complete seal between the mask and the face. - Anyone who is not able to see long distance without glasses or contacts.


NCT ID:

NCT02482571


Primary Contact:

Principal Investigator
Silvia Mangia, PhD
University of Minnesota - Clinical and Translational Science Institute


Backup Contact:

N/A


Location Contact:

Minneapolis, Minnesota 55455
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 23, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.